Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Occupational Exposition to Pesticides and Amyotrophic Lateral Sclerosis in Quebec and France
General Neurology
P9 - Poster Session 9 (12:00 PM-1:00 PM)
6-007
The objective of this study was to test the hypothesis that amyotrophic lateral sclerosis (ALS) was associated with previous exposition to pesticides.
The association between the use of pesticides and the development of ALS remains uncertain. Many previous studies were based on registry data or on a small number of observations.

Incident and prevalent ALS patients were recruited in Quebec and France along with a control group composed of relatives of ALS and Parkinson patients and patients from neurology clinics not suffering from neurodegenerative disorders. Exposition was evaluated by a phone-administered questionnaire in which patients were asked whether they had occupied a list of at-risk jobs, and then whether they had actually used pesticides in this occupational setting. Results were analysed with unadjusted and adjusted unconditional logistic regression taking as covariates age, gender, cigarette smoking, and head trauma history.

403 cases and 381 controls were included. Mean age at questionnaire was 59.2 years (±11.8 years) in cases and 58.8 years (±11.1 years) in controls, and 85 cases (21.1%) presented with bulbar onset. At-risk occupation was reported in 85 cases (21.1%) and 37 controls (9.7%), which yielded an unadjusted OR of 2.48 (95%CI 1.65-3.80; p<0.0001), and an adjusted OR of 2.00 (95%CI 1.31-3.11; p=0.002) when controlling for age, gender, smoking, and head trauma. Actual occupational exposition to pesticides was reported in 45 cases (11.2%) and 22 controls (5.8%), for an unadjusted OR of 2.05 (95%CI 1.22-3.54; p=0.008) and an adjusted OR of 1.53 (95%CI 0.89-2.69; p=0.13). There was no statistical interaction between gender, head trauma and at-risk occupation or actual pesticide occupational exposition.

Our results show an association between occupations at high risk for pesticides exposition and ALS, but this association was not statistically significant when we considered only actual exposition to pesticides in these occupational settings in a multivariate analysis.

Authors/Disclosures
Marie Beaudin, MD
PRESENTER
Dr. Beaudin has nothing to disclose.
Anne-Marie Trudelle, MD Dr. Trudelle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Trudelle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Trudelle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Trudelle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Trudelle has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Trudelle has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Trudelle has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Trudelle has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Trudelle has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Trudelle has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme.
No disclosure on file
No disclosure on file
No disclosure on file
Nicolas Dupre, MD, FÂé¶¹´«Ã½Ó³»­ (CHU de Quebec - U Laval) Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.